A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors
Intra-IMMUSG Pte Ltd
Intra-IMMUSG Pte Ltd
National Institutes of Health Clinical Center (CC)
GlaxoSmithKline
Eli Lilly and Company
USWM, LLC (dba US WorldMeds)
Amgen
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
EMD Serono
National Institutes of Health Clinical Center (CC)
USWM, LLC (dba US WorldMeds)
USWM, LLC (dba US WorldMeds)
M.D. Anderson Cancer Center
Georgetown University
Astellas Pharma Inc
Actuate Therapeutics Inc.
Grupo Espanol de Tumores Neuroendocrinos
Boston Scientific Corporation
Cellectar Biosciences, Inc.
Center for International Blood and Marrow Transplant Research
AstraZeneca
AstraZeneca
Emory University
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
University of Wisconsin, Madison
University of California, San Diego
St. Jude Children's Research Hospital
Centre Leon Berard
M.D. Anderson Cancer Center
Brigham and Women's Hospital
TaiRx, Inc.
AbbVie
St. Jude Children's Research Hospital
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
AbbVie
AbbVie
University of Colorado, Denver
University of California, San Diego
Blokhin's Russian Cancer Research Center
SOLTI Breast Cancer Research Group
Proton Collaborative Group
AbbVie
AbbVie
PharmaEssentia
AbbVie
UNICANCER